H. Pylori Blood Test Reliability
H. pylori blood (serologic) tests are NOT reliable for diagnosing active infection and should not be used for this purpose. 1
Critical Limitation: Cannot Distinguish Active from Past Infection
Serologic tests detect antibodies (IgG) that indicate exposure to H. pylori at some point in time, but cannot differentiate between currently active infection and previously eradicated infection. 1 This is the fundamental flaw that makes blood tests unsuitable for diagnosing active disease.
Key Problems with Blood Tests:
- Antibody levels remain elevated for years after successful eradication, creating a "serologic scar" that produces false-positive results 1
- Sensitivity and specificity are only approximately 85-90%, which is inadequate for clinical decision-making 1
- In populations with low disease prevalence, the positive predictive value falls dramatically, leading to unnecessary treatment 1
- Office-based whole blood tests are even less accurate than laboratory ELISA tests (sensitivity as low as 36-42% in some studies), though they provide results within 30 minutes 2, 3, 4
Recommended Tests for Active Infection
Use urea breath test (UBT) or stool antigen test instead—both have sensitivity and specificity >90% for detecting active infection. 1
Urea Breath Test (UBT):
- Gold standard for noninvasive diagnosis of active infection 1
- Requires ingestion of ¹³C or ¹⁴C-labeled urea; H. pylori metabolizes it, producing labeled CO₂ measured in breath 1
- Must withhold antibiotics and bismuth for ≥4 weeks, PPIs for ≥7 days, and fast for ≥6 hours before testing to avoid false-negatives 1
Stool Antigen Test:
- Comparable accuracy to UBT (sensitivity and specificity >90%) 1
- Can be used interchangeably with UBT for initial diagnosis 1
- Also affected by recent antibiotic, bismuth, or PPI use 1
Limited Acceptable Use of Serology
Blood tests should ONLY be used for initial diagnosis when there is very high pretest probability (e.g., active duodenal ulcer), and even then, active infection must be confirmed with UBT or stool antigen test before starting treatment. 1
Absolute Contraindications for Blood Tests:
- Never use serology to confirm cure after treatment—antibodies persist despite eradication 1
- Avoid in populations where many patients have been previously treated, as false-positives will be common 1
- Do not use IgA or IgM tests—these are not FDA-approved and have poor specificity/sensitivity 1
Clinical Pitfall to Avoid
The most common error is ordering serologic tests from commercial laboratories that offer non-FDA-approved "in-house" tests or panels combining IgG/IgA/IgM. 1 These provide no added benefit and often have unclear diagnostic value. Always request only FDA-approved IgG tests if serology must be used, though active infection testing is strongly preferred. 1